The tumor markers carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA 19-9), and cancer antigen 125 (CA-125) can be used to estimate the extent of disease in patients with primary colon cancer. Here, CEACAM5 is linked to neoplasm.